Related references
Note: Only part of the references are listed.Modeling Human Muscular Dystrophies in Zebrafish: Mutant Lines, Transgenic Fluorescent Biosensors, and Phenotyping Assays
Chiara Tesoriero et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
bdnf loss affects activity, sociability, and anxiety-like behaviour in zebrafish
Tyrone Lucon-Xiccato et al.
BEHAVIOURAL BRAIN RESEARCH (2023)
Simultaneous imaging of calcium and contraction in the beating heart of zebrafish larvae
Jussep Salgado-Almario et al.
THERANOSTICS (2022)
Long-term non-invasive drug treatments in adult zebrafish that lead to melanoma drug resistance
Yuting Lu et al.
DISEASE MODELS & MECHANISMS (2022)
Mitochondrial stress responses in Duchenne muscular dystrophy: metabolic dysfunction or adaptive reprogramming?
Catherine A. Bellissimo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)
Zebrafish Larvae Behavior Models as a Tool for Drug Screenings and Pre-Clinical Trials: A Review
Joao Gabriel Santos Rosa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The Many Roles of Macrophages in Skeletal Muscle Injury and Repair
Xingyu Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
CRISPR-Cas9-induced gene knockout in zebrafish
Raghavender Medishetti et al.
STAR PROTOCOLS (2022)
Circadian rhythms in zebrafish (Danio rerio) behaviour and the sources of their variability
Viacheslav V. Krylov et al.
BIOLOGICAL REVIEWS (2021)
Treatment with a triazole inhibitor of the mitochondrial permeability transition pore fully corrects the pathology of sapje zebrafish lacking dystrophin
Anna Stocco et al.
PHARMACOLOGICAL RESEARCH (2021)
An Automated Low-Cost Swim Tunnel for Measuring Swimming Performance in Fish
Tyrone Lucon-Xiccato et al.
ZEBRAFISH (2021)
Muscular dystrophy: Experimental animal models and therapeutic approaches (Review)
Gisela Gaina et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies
Satvik Mareedu et al.
FRONTIERS IN PHYSIOLOGY (2021)
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
E. Elizabeth Patton et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Sarcoglycanopathies: an update
Mariz Vainzof et al.
NEUROMUSCULAR DISORDERS (2021)
Progress in Gene-Editing Technology of Zebrafish
Yanling Li et al.
BIOMOLECULES (2021)
Analysis of behavioral changes in zebrafish (Danio rerio) larvae caused by aminoglycoside-induced damage to the lateral line and muscles
Eunjung Han et al.
NEUROTOXICOLOGY (2020)
Potential of the zebrafish model for the forensic toxicology screening of NPS: A comparative study of the effects of APINAC and methiopropamine on the behavior of zebrafish larvae and mice
Elisa Morbiato et al.
NEUROTOXICOLOGY (2020)
New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy
Jorge Alonso-Perez et al.
BRAIN (2020)
Zebrafish (Danio rerio) physiological and behavioural responses to insect-based diets: a multidisciplinary approach
Matteo Zarantoniello et al.
Scientific Reports (2020)
A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy
Gist H. Farr et al.
SKELETAL MUSCLE (2020)
Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients
Zhiying Xie et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Genetic compensation triggered by mutant mRNA degradation
Mohamed A. El-Brolosy et al.
NATURE (2019)
Swimming capability of zebrafish is governed by water temperature, caudal fin length and genetic background
Yuma Wakamatsu et al.
SCIENTIFIC REPORTS (2019)
Sel1l knockdown negatively influences zebrafish embryos endothelium
Andrea Barbieri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Regulation of fibrosis in muscular dystrophy
Lucas R. Smith et al.
MATRIX BIOLOGY (2018)
229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017
Volker Straub et al.
NEUROMUSCULAR DISORDERS (2018)
Different outcome of sarcoglycan missense mutation between human and mouse
Sara F. Henriques et al.
PLOS ONE (2018)
Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin
C. T. Chang et al.
JOURNAL OF FISH DISEASES (2017)
Number of inadvertent RNA targets for morpholino knockdown in Danio rerio is largely underestimated: evidence from the study of Ser/Arg-rich splicing factors
Marine Joris et al.
NUCLEIC ACIDS RESEARCH (2017)
Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy
Marco Schiavone et al.
PHARMACOLOGICAL RESEARCH (2017)
Maternal cortisol stimulates neurogenesis and affects larval behaviour in zebrafish
Carol Best et al.
SCIENTIFIC REPORTS (2017)
Emerging therapeutic strategies for sarcoglycanopathy
Marcello Carotti et al.
EXPERT OPINION ON ORPHAN DRUGS (2017)
The sarcoglycan complex in skeletal muscle
Hakan Tarakci et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2016)
Forty years later: Mitochondria as therapeutic targets in muscle diseases
Alessandra Zulian et al.
PHARMACOLOGICAL RESEARCH (2016)
Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy
Jeffrey J. Widrick et al.
PHYSIOLOGICAL GENOMICS (2016)
Pathogenesis, clinical features and diagnosis of sarcoglycanopathies
Corrado Angelini et al.
EXPERT OPINION ON ORPHAN DRUGS (2016)
Reverse Genetic Screening Reveals Poor Correlation between Morpholino-Induced and Mutant Phenotypes in Zebrafish
Fatma O. Kok et al.
DEVELOPMENTAL CELL (2015)
The Light Wavelength Affects the Ontogeny of Clock Gene Expression and Activity Rhythms in Zebrafish Larvae
Viviana Di Rosa et al.
PLOS ONE (2015)
Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiency
Avnika A. Ruparelia et al.
ACTA NEUROPATHOLOGICA (2014)
Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D
Elisa Bianchini et al.
HUMAN MOLECULAR GENETICS (2014)
The E3 Ubiquitin Ligase gp78 Protects against ER Stress in Zebrafish Liver
Zhiliang Chen et al.
JOURNAL OF GENETICS AND GENOMICS (2014)
CARDIAC INVOLVEMENT IN DUTCH PATIENTS WITH SARCOGLYCANOPATHY: A CROSS-SECTIONAL COHORT AND FOLLOW-UP STUDY
Steven M. Schade van Westrum et al.
MUSCLE & NERVE (2014)
The zebrafish reference genome sequence and its relationship to the human genome
Kerstin Howe et al.
NATURE (2013)
Rescue of Sarcoglycan Mutations by Inhibition of Endoplasmic Reticulum Quality Control is Associated with Minimal Structural Modifications
Tayebeh Soheili et al.
HUMAN MUTATION (2012)
Protective Role of Cell Division Cycle 48 (CDC48) Protein against Neurodegeneration via Ubiquitin-Proteasome System Dysfunction during Zebrafish Development
Shintaro Imamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Drug screening in a zebrafish model of Duchenne muscular dystrophy
Genri Kawahara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies
Sanne A. B. Hermsen et al.
TOXICOLOGY IN VITRO (2011)
delta-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches
Alison M. Blain et al.
SKELETAL MUSCLE (2011)
T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases
Lama Al-Qusairi et al.
SKELETAL MUSCLE (2011)
The ubiquitin proteasome system is required for cell proliferation of the lens epithelium and for differentiation of lens fiber cells in zebrafish
Fumiyasu Imai et al.
DEVELOPMENT (2010)
Our trails and trials in the subsarcolemmal cytoskeleton network and muscular dystrophy researches in the dystrophin era
Eijiro Ozawa
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2010)
Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol
R. C. MacPhail et al.
NEUROTOXICOLOGY (2009)
Inhibition of proteasome activity promotes the correct localization of disease-causing α-sarcoglycan mutants in HEK-293 cells constitutively expressing β-, γ-, and δ-sarcoglycan
Stefano Gastaldello et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice
Kazuhiro Kobuke et al.
HUMAN MOLECULAR GENETICS (2008)
Mannosidase I inhibition rescues the human α-sarcoglycan R77C recurrent mutation
Marc Bartoli et al.
HUMAN MOLECULAR GENETICS (2008)
Animal models for genetic neuromuscular diseases
Mariz Vainzof et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum
Yan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Modulation of locomotor activity in larval zebrafish during light adaptation
Harold A. Burgess et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2007)
Zebrafish orthologs of human muscular dystrophy genes
Leta S. Steffen et al.
BMC GENOMICS (2007)
δ-sarcoglycan is necessary for early heart and muscle development in zebrafish
Lu Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
δ-Sarcoglycan is required for early zebrafish muscle organization
JR Guyon et al.
EXPERIMENTAL CELL RESEARCH (2005)
Cardiomyopathy in muscular dystrophies
F Muntoni
CURRENT OPINION IN NEUROLOGY (2003)
Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: Calcineurin/PP2B activity in the heart of J2N-k hamster
S Mitsuhashi et al.
JOURNAL OF BIOCHEMISTRY (2003)
LGMD2E patients risk developing dilated cardiomyopathy
M Fanin et al.
NEUROMUSCULAR DISORDERS (2003)
Cardiac morphology and blood pressure in the adult zebrafish
N Hu et al.
ANATOMICAL RECORD (2001)
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies
L Politano et al.
NEUROMUSCULAR DISORDERS (2001)
Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E
M Durbeej et al.
MOLECULAR CELL (2000)
Share Paper
